Yin, Feng
Ma, Jinzhong
Xiao, Haijun
Ao, Rongguang
Zhang, Fengqi
Li, Wencui
Wang, Wei
Zeng, Peter
Lu, Tracy
Revel, Frédérique Bariguian
Araga, Mako
Patel, Shiva
Moreira, Sebastian
Zhang, Junfei
Zhang, Weibin
Funding for this research was provided by:
GSK Consumer Healthcare
Article History
Received: 29 April 2022
Accepted: 9 December 2022
First Online: 24 December 2022
Declarations
:
: The final study protocol and amendments, informed consent, and other relevant information were approved by the 15 ethics committees at each of the 15 participating sites listed in the Methods section in accordance with China’s good clinical practice and other applicable China-specific requirements. The study was conducted in accordance with International Conference on Harmonisation and the ethical principles of the Declaration of Helsinki. Written, informed consent was obtained from each subject prior to any study-specific procedures.
: Not applicable.
: FY, JM, HX, RA, FZ, WL, WW, and WZ are investigators for GSK Consumer Healthcare.PZ, TL, FBR, MA, SP, and SM are employees of GSK Consumer Healthcare.JZ was an employee of GSK Consumer Healthcare at the time of this study.